Publix Triple Antibiotic Ointment
NDC Package 56062-830-28

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Publix Triple Antibiotic (bacitracin zinc 400 u, polymxyin b sulfate 5, 000 u, neomycin sulfate 3.5mg/g) ointment is clean the affected areaapply a small amount (equal to surface area of tip of finger) on the area 1 to 3 times daily.may be covered with a sterile bandage. This formulation utilizes a ointment delivery system. Marketed by Publix Super Markets, Inc., this product is identified by NDC 56062-830 and is authorized under FDA application M004.

Identification & Billing

NDC Package Code
56062-830-28
Package Description
1 TUBE in 1 CARTON / 28 g in 1 TUBE
Product Code
56062-830
11-Digit Billing Format
56062083028
RxNorm Crosswalk
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
  • RxCUI: 204602 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment

Clinical Specifications

Proprietary Name
Publix Triple Antibiotic
Non-Proprietary Name
Bacitracin Zinc 400 U, Polymxyin B Sulfate 5, 000 U, Neomycin Sulfate 3.5mg/g
Substance Name
Bacitracin Zinc; Neomycin Sulfate; Polymyxin B Sulfate
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Clean the affected areaapply a small amount (equal to surface area of tip of finger) on the area 1 to 3 times daily.may be covered with a sterile bandage

Regulatory & Marketing

Labeler Name
Publix Super Markets, Inc.
Product Type
Human Otc Drug
FDA Application #
M004
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-15-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 56062-830-28 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Publix Triple Antibiotic, a human over the counter drug labeled by Publix Super Markets, Inc.. This ointment is formulated for topical use and contains bacitracin zinc; neomycin sulfate; polymyxin b sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Publix Super Markets, Inc. on July 15, 2024. The current certification is valid through December 31, 2026.

How is this Publix Super Markets, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 56062083028. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
56062-830-28
11-Digit CMS (5-4-2)
56062-0830-28

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.